Here, we provided further evidence supporting the argument that in regions vulnerable to disease, increased synthesis of tau, rather than dysregulated tau degradation, is a critical pathogenic aspect of abnormal tau proteostasis in PSP. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.